← Back to Vaccine Database

RSV A2

Live attenuated vaccine · VDDBV0656

Target & Classification

RSVRespiratory syncytial virus
Live attenuated vaccine
Upper respiratory tract
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT03388645 Phase 1Upper respiratory tract
NCT02484417 Phase 1Upper respiratory tract